A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
The Department of Health (DOH) on Friday provided free cervical and breast cancer screening to public school teachers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results